Cutting back on artificial sweeteners in pregnancy and breastfeeding
Tests cutting artificial sweeteners in pregnant women who use them often.
Key facts
- Who runs it
- George Washington University
- Where
- Washington D.C., United StatesSee the site
- Trial code
- Registry title
- Effects of a Non-nutritive Sweetener Reduction Intervention in Pregnancy and Lactation on Maternal and Infant Outcomes
- Status
- Recruiting
- People taking part
- 324 people, planned
- Started
- 19 Aug 2024
- Expected to end
- 1 Feb 2029
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- NNS Restriction Intervention
- Control Intervention
- Record updated
- 18 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women, early in pregnancy, who often drink drinks with non-nutritive (zero-calorie) sweeteners and plan to breastfeed. Their babies can also join.
- Age
- 18 to 45 years
- Sex
- Women only
- Disease stage
- Pregnant with one baby, at 16 weeks of pregnancy or less.
Main reasons for not taking part
- Use of medicines that may affect body weight, body build, insulin resistance or blood fats, such as metformin or GLP-1 agonists
- Tobacco or drug use, or more than 1 alcoholic drink per week, during pregnancy
- Existing bowel, inflammatory or absorption disorders, such as Crohn's disease or ulcerative colitis
- Known or suspected genetic problems or birth defects in the baby
- Past gastric bypass surgery
This trial only enrols pregnant participants. The registry sentence this rests on: * Pregnant
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Pregnant
- ≤ 16 weeks gestation
- Singleton pregnancy
- Report frequent NNS beverage consumption (≥ 7 servings/week)
- 18-45 years of age
- Able to read English at a 5th grade level; and
- Intend to breastfeed for at least the first 6 months of life
- For infants: The mother must be enrolled and provide assent for the infant to participate
Who cannot take part
- Medication (e.g., metformin; GLP-1 agonists) use that may affect body weight, body composition, insulin resistance, or lipid profiles
- Tobacco or drug use during pregnancy
- History of prior gastric bypass surgery
- Pre-existing gastrointestinal, inflammatory, or malabsorptive disorders (e.g., - Crohn's disease, ulcerative colitis, inflammatory bowel disease) that may impact NNS absorption or gut microbiota
- Physical or mental concerns preventing study participation
- Alcohol consumption (\>1 drink per week) during pregnancy
- Known suspected/confirmed genetic fetal abnormalities or suspected or known congenital birth defects
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
This trial is currently available in United States.
- The George Washington UniversityWashington D.C., United StatesContact: Allison C Sylvetsky, PhDTaking people
About the trial
What the trial wants to find out
The effects of consuming non-nutritive sweeteners (NNS) during pregnancy and lactation on infant obesity and cardiometabolic disease risk are not well understood. In this project, pregnant women who frequently consume NNS will be randomly assigned to an NNS-restriction intervention (NNS restriction during pregnancy and lactation or during lactation only) or a control group (no NNS restriction) to determine whether NNS consumption during pregnancy and/or lactation affects infant body composition, maternal blood sugar during pregnancy, and the infants' gut microbiome and metabolome. The results of this study have the potential to shape recommendations around NNS consumption during pregnancy and lactation, thereby potentially improving maternal and infant metabolic health and reducing the global burden of obesity and cardiometabolic disease.
The 3 groups in the trial
- Control (Group 1)Existing treatment, for comparison
Participants in this arm will continue their usual consumption of NNS throughout pregnancy and lactation without any intervention. They will not receive any specific NNS-restriction intervention.
Treatment: Control Intervention
- NNS Restriction in Lactation (Group 2)Existing treatment, for comparison
Participants in this arm will maintain their usual NNS consumption during pregnancy but will receive an intervention to restrict NNS intake during lactation.
Treatment: NNS Restriction Intervention and Control Intervention
- NNS Restriction in Pregnancy and Lactation (Group 3)Existing treatment, for comparison
Participants in this arm will receive an intervention to restrict NNS intake both during pregnancy and lactation.
Treatment: NNS Restriction Intervention
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of a Non-nutritive Sweetener Reduction Intervention in Pregnancy and Lactation on Maternal and Infant Outcomes (the SweetPea Trial)
- Plain-language title
- Cutting back on artificial sweeteners in pregnancy and breastfeedingGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06548828, who can take part
- Record updated
- 18 February 2026